文献速递心力衰竭与心肌病

靶向炎症细胞因子Igfbp7的心力衰竭疫苗治疗

Vaccine Therapy for Heart Failure Targeting the Inflammatory Cytokine Igfbp7.
PubMed 文献 · Circulation · 2024-07-11

该研究在小鼠横向主动脉缩窄压力超负荷模型中,发现心脏内皮细胞因血管增生出现复制应激与DNA损伤并衰老,衰老内皮细胞上调Igfbp7,抑制心肌胰岛素信号与氧化磷酸化。内皮特异性敲除Igfbp7或接种靶向Igfbp7的疫苗均可改善压力超负荷下的心功能障碍,提示该疫苗策略可能用于预防心力衰竭发生。

要点

  • 压力超负荷使心脏内皮细胞复制应激与DNA损伤累积并衰老,上调Igfbp7。
  • Igfbp7过表达加重心功能障碍,内皮特异性敲除或疫苗靶向可改善。
  • 靶向Igfbp7的疫苗治疗可能成为预防心力衰竭的新策略。

核心结论

  • 衰老内皮细胞产生的Igfbp7导致心功能障碍,靶向Igfbp7的疫苗治疗可能有助于预防心力衰竭发生。

研究设计与样本

  • 小鼠经横向主动脉缩窄造成压力超负荷,用组织透明化技术观察心脏血管结构。
  • 对野生型小鼠与内皮特异性基因敲除小鼠心脏行单细胞RNA测序等功能与分子分析。
  • 用心组织毛细管电泳-飞行时间质谱系统检测代谢物。
  • 疫苗由合成表位肽与钥孔戚血蓝蛋白偶联、以氢氧化铝为佐剂制备并给予小鼠。
  • 使用心力衰竭患者组织样本行单核RNA测序,分析内皮细胞基因表达及心肌细胞通路。

主要发现

  • 压力超负荷诱导小鼠心脏形成错综缠绕的血管,导致心脏内皮细胞复制应激与DNA损伤累积。
  • 用细胞周期蛋白依赖性激酶抑制剂抑制细胞增殖可减少内皮细胞DNA损伤并改善横向主动脉缩窄所致心功能障碍。
  • 单细胞RNA测序显示衰老内皮细胞Igfbp7表达上调,小鼠与人类衰竭心脏心肌细胞胰岛素信号与氧化磷酸化下调。
  • 用AAV9在小鼠心脏过表达Igfbp7加重心功能障碍。
  • 内皮特异性敲除Igfbp7及靶向Igfbp7的疫苗改善压力超负荷下心功能障碍,并增加心肌细胞氧化磷酸化。

临床怎么用

  • 研究提示Igfbp7可作为心力衰竭预防的候选疫苗靶点,但尚处动物实验阶段,未提供临床用药方案。

局限性

  • 证据主要来自小鼠压力超负荷模型,人体数据限于组织单核RNA测序分析,疫苗尚未在人群验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The heart comprises many types of cells such as cardiomyocytes, endothelial cells (ECs), fibroblasts, smooth muscle cells, pericytes, and blood cells. Every cell type responds to various stressors (eg, hemodynamic overload and ischemia) and changes its properties and interrelationships among cells. To date, heart failure research has focused mainly on cardiomyocytes; however, other types of cells and their cell-to-cell interactions might also be important in the pathogenesis of heart failure. METHODS: Pressure overload was imposed on mice by transverse aortic constriction and the vascular structure of the heart was examined using a tissue transparency technique. Functional and molecular analyses including single-cell RNA sequencing were performed on the hearts of wild-type mice and EC-specific gene knockout mice. Metabolites in heart tissue were measured by capillary electrophoresis-time of flight-mass spectrometry system. The vaccine was prepared by conjugating the synthesized epitope peptides with keyhole limpet hemocyanin and administered to mice with aluminum hydroxide as an adjuvant. Tissue samples from heart failure patients were used for single-nucleus RNA sequencing to examine gene expression in ECs and perform pathway analysis in cardiomyocytes. RESULTS: Pressure overload induced the development of intricately entwined blood vessels in murine hearts, leading to the accumulation of replication stress and DNA damage in cardiac ECs. Inhibition of cell proliferation by a cyclin-dependent kinase inhibitor reduced DNA damage in ECs and ameliorated transverse aortic constriction-induced cardiac dysfunction. Single-cell RNA sequencing analysis revealed upregulation of Igfbp7 (insulin-like growth factor-binding protein 7) expression in the senescent ECs and downregulation of insulin signaling and oxidative phosphorylation in cardiomyocytes of murine and human failing hearts. Overexpression of Igfbp7 in the murine heart using AAV9 (adeno-associated virus serotype 9) exacerbated cardiac dysfunction, while EC-specific deletion of Igfbp7 and the vaccine targeting Igfbp7 ameliorated cardiac dysfunction with increased oxidative phosphorylation in cardiomyocytes under pressure overload. CONCLUSIONS: Igfbp7 produced by senescent ECs causes cardiac dysfunction and vaccine therapy targeting Igfbp7 may be useful to prevent the development of heart failure.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Katoh, Nomura, Yamada, et al. Vaccine Therapy for Heart Failure Targeting the Inflammatory Cytokine Igfbp7. Circulation. 2024. PMID: 38991046. doi:10.1161/CIRCULATIONAHA.123.064719

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。